Masimo Corp is a global medical technology company that specializes in non-invasive patient monitoring devices. The company was founded in 1989 by Joe Kiani, an electrical engineer, and began its operations in Irvine, California. Masimo is dedicated to improving patient outcomes and reducing healthcare costs through its innovative monitoring solutions.
Masimo Corp develops and manufactures a wide range of medical devices and sensors, including pulse oximeters, capnography monitors, and continuous monitoring systems. These devices are used by healthcare professionals to monitor vital signs, such as oxygen saturation, pulse rate, and respiration, in both clinical and homecare settings. Masimo's technology is based on its proprietary Signal Extraction Technology (SET), which provides accurate measurements even in challenging conditions, such as motion or low perfusion.
As a company listed on the Nasdaq stock exchange under the ticker symbol "MASI," Masimo offers investors the opportunity to invest in the rapidly growing field of medical technology. The company has a strong presence in the global market, with its products being used in over 200 countries and adopted by healthcare institutions worldwide.
Masimo Corp has a commitment to innovation and research. The company invests heavily in research and development to continuously improve its technology and develop new solutions. Masimo has obtained numerous patents and has received recognition for its contributions to the field of medical technology.
Masimo's flagship product is its SET pulse oximetry technology, which revolutionized the accuracy and reliability of pulse oximeters. SET technology measures oxygen saturation and pulse rate by analyzing the patient's arterial blood through light absorption. It has been proven to provide more accurate readings, especially in challenging clinical conditions. This technology has set a new standard in pulse oximetry and is widely adopted by healthcare professionals globally.